BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24086308)

  • 1. Unique structure and dynamics of the EphA5 ligand binding domain mediate its binding specificity as revealed by X-ray crystallography, NMR and MD simulations.
    Huan X; Shi J; Lim L; Mitra S; Zhu W; Qin H; Pasquale EB; Song J
    PLoS One; 2013; 8(9):e74040. PubMed ID: 24086308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor.
    Qin H; Shi J; Noberini R; Pasquale EB; Song J
    J Biol Chem; 2008 Oct; 283(43):29473-84. PubMed ID: 18708347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein dynamics at Eph receptor-ligand interfaces as revealed by crystallography, NMR and MD simulations.
    Qin H; Lim L; Song J
    BMC Biophys; 2012 Jan; 5():2. PubMed ID: 22277260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.
    Qin H; Noberini R; Huan X; Shi J; Pasquale EB; Song J
    J Biol Chem; 2010 Jan; 285(1):644-54. PubMed ID: 19875447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sizes of interface residues account for cross-class binding affinity patterns in Eph receptor-ephrin families.
    Guo FY; Lesk AM
    Proteins; 2014 Mar; 82(3):349-53. PubMed ID: 24105818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.
    Bowden TA; Aricescu AR; Nettleship JE; Siebold C; Rahman-Huq N; Owens RJ; Stuart DI; Jones EY
    Structure; 2009 Oct; 17(10):1386-97. PubMed ID: 19836338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.
    Goldgur Y; Paavilainen S; Nikolov D; Himanen JP
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):71-4. PubMed ID: 19193989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the EphB6 receptor ectodomain.
    Mason EO; Goldgur Y; Robev D; Freywald A; Nikolov DB; Himanen JP
    PLoS One; 2021; 16(3):e0247335. PubMed ID: 33770085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first identification of complete Eph-ephrin signalling in ctenophores and sponges reveals a role for neofunctionalization in the emergence of signalling domains.
    Krishnan A; Degnan BM; Degnan SM
    BMC Evol Biol; 2019 Apr; 19(1):96. PubMed ID: 31023220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
    Xu K; Tzvetkova-Robev D; Xu Y; Goldgur Y; Chan YP; Himanen JP; Nikolov DB
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14634-9. PubMed ID: 23959867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into ligand-binding pocket formation in Nurr1 by molecular dynamics simulations.
    Windshügel B
    J Biomol Struct Dyn; 2019 Oct; 37(17):4651-4657. PubMed ID: 30582418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP; Henkemeyer M; Nikolov DB
    Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR structure and dynamics of human ephrin-B2 ectodomain: the functionally critical C-D and G-H loops are highly dynamic in solution.
    Ran X; Qin H; Liu J; Fan JS; Shi J; Song J
    Proteins; 2008 Aug; 72(3):1019-29. PubMed ID: 18300229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptor.
    Lamberto I; Lechtenberg BC; Olson EJ; Mace PD; Dawson PE; Riedl SJ; Pasquale EB
    ACS Chem Biol; 2014 Dec; 9(12):2787-95. PubMed ID: 25268696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
    Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
    J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ephrin-A5 and EphA5 interaction induces synaptogenesis during early hippocampal development.
    Akaneya Y; Sohya K; Kitamura A; Kimura F; Washburn C; Zhou R; Ninan I; Tsumoto T; Ziff EB
    PLoS One; 2010 Aug; 5(8):e12486. PubMed ID: 20824214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor.
    Lamberto I; Qin H; Noberini R; Premkumar L; Bourgin C; Riedl SJ; Song J; Pasquale EB
    Biochem J; 2012 Jul; 445(1):47-56. PubMed ID: 22489865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
    Koolpe M; Burgess R; Dail M; Pasquale EB
    J Biol Chem; 2005 Apr; 280(17):17301-11. PubMed ID: 15722342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
    Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Eph receptors and ephrins in segmental patterning.
    Xu Q; Mellitzer G; Wilkinson DG
    Philos Trans R Soc Lond B Biol Sci; 2000 Jul; 355(1399):993-1002. PubMed ID: 11128993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.